GILD240802P71000
- 0.02
- -0.03-60.00%
Gilead Sciences Newsroom
Disney, Super Micro, Uber, and More Stocks to Watch
19 Out of 21 Healthcare Companies Topped Profit Estimates This Week: Earnings Scorecard
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Should You Buy, Sell or Hold Gilead Sciences (GILD) Before Q2 Earnings?
Gilead Sciences (GILD) Advances While Market Declines: Some Information for Investors
Gilead Sciences (GILD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Favorite High-yield Dividend Stocks - BMO
Here Is What to Know Beyond Why Gilead Sciences, Inc. (GILD) Is a Trending Stock
Gilead Sciences's Options Frenzy: What You Need to Know
Center for Disease Analysis Foundation Awards Second Round of Grants for the CDAF-Relink Program
Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know
$100 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today
Compugen Gets US FDA Approval for Solid Tumor Treatment Study
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
How to Boost Your Portfolio With Top Medical Stocks Set to Beat Earnings
Most U.S. Pharmas Don't Pay Any U.S. Income Tax
Gilead Sciences, Inc.'s (NASDAQ:GILD) One-year Returns Climbed After Last Week's 6.1% Gain, Institutional Investors Must Be Happy
Gilead Sciences Options Spot-On: On July 26th, 72,710 Contracts Were Traded, With 296.52K Open Interest
10 Health Care Stocks Whale Activity In Today's Session
Unusual Options Activity: GILD, COIN and Others Attract Market Bets, GILD V/OI Ratio Reaches 67.0